November 17, 2026 at 02:44 PM UTC
Pacira BioSciences, Inc. reports material agreement in SEC 8-K
Pacira BioSciences, Inc. filed an 8-K covering a material definitive agreement, termination of a material definitive agreement, an acquisition or disposition of assets, and a triggering event affecting a financial obligation. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 17, 2026 at 02:42 PM UTC
Open official source